• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆细胞外囊泡细胞因子谱作为帕金森病进展的生物标志物。

Cytokine profiles of plasma extracellular vesicles as progression biomarkers in Parkinson's disease.

机构信息

Department of Neurology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.

Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

出版信息

Aging (Albany NY). 2023 Mar 9;15(5):1603-1614. doi: 10.18632/aging.204575.

DOI:10.18632/aging.204575
PMID:36897204
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10042681/
Abstract

BACKGROUND

Inflammation contributes substantially to the pathogenesis of Parkinson's disease (PD). Plasma extracellular vesicle (EV)-derived cytokines are emerging biomarkers of inflammation. We conducted a longitudinal study of the plasma EV-derived cytokine profiles of people with PD (PwP).

METHODS

A total of 101 people with mild to moderate PD and 45 healthy controls (HCs) were recruited, and they completed motor assessments (Unified Parkinson Disease Rating Scale [UPDRS]) and cognitive tests at baseline and 1-year follow-up. We isolated the participants' plasma EVs and analyzed their levels of cytokines, including interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor (TNF)-α, and transforming growth factor (TGF)-β.

RESULTS

We noted no significant changes in the plasma EV-derived cytokine profiles of the PwPs and HCs between baseline and the 1-year follow-up. Among the PwP, changes in plasma EV-derived IL-1β, TNF-α and IL-6 levels were significantly associated with changes in the severity of postural instability and gait disturbance (PIGD) and cognition. Baseline plasma EV-derived IL-1β, TNF-α, IL-6, and IL-10 levels were significantly associated with the severity of PIGD and cognitive symptoms at follow-up, and PwP with elevated IL-1β and IL-6 levels exhibited significant progression of PIGD over the study period.

CONCLUSION

These results suggested the role of inflammation in PD progression. In addition, baseline levels of plasma EV-derived proinflammatory cytokines can be used to predict the progression of PIGD, the most severe motor symptom of PD. Additional studies with longer follow-up periods are necessary, and plasma EV-derived cytokines may serve as effective biomarkers of PD progression.

摘要

背景

炎症在帕金森病(PD)的发病机制中起重要作用。血浆细胞外囊泡(EV)衍生细胞因子是炎症的新兴生物标志物。我们对 PD 患者(PwP)的血浆 EV 衍生细胞因子谱进行了纵向研究。

方法

共招募了 101 名轻度至中度 PD 患者和 45 名健康对照者(HCs),他们在基线和 1 年随访时完成了运动评估(统一帕金森病评定量表[UPDRS])和认知测试。我们分离了参与者的血浆 EV,并分析了细胞因子的水平,包括白细胞介素(IL)-1β、IL-6、IL-10、肿瘤坏死因子(TNF)-α和转化生长因子(TGF)-β。

结果

我们没有注意到 PwP 和 HCs 的血浆 EV 衍生细胞因子谱在基线和 1 年随访之间有显著变化。在 PwP 中,血浆 EV 衍生的 IL-1β、TNF-α 和 IL-6 水平的变化与姿势不稳和步态障碍(PIGD)和认知的严重程度变化显著相关。基线血浆 EV 衍生的 IL-1β、TNF-α、IL-6 和 IL-10 水平与随访时 PIGD 和认知症状的严重程度显著相关,且 IL-1β 和 IL-6 水平升高的 PwP 在研究期间 PIGD 显著进展。

结论

这些结果表明炎症在 PD 进展中的作用。此外,基线血浆 EV 衍生促炎细胞因子水平可用于预测 PIGD 的进展,PIGD 是 PD 最严重的运动症状。需要进行更长随访期的进一步研究,并且血浆 EV 衍生细胞因子可能是 PD 进展的有效生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/10042681/c0a11704cf8f/aging-15-204575-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/10042681/eaacb3a74c17/aging-15-204575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/10042681/7df15528ee92/aging-15-204575-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/10042681/c0a11704cf8f/aging-15-204575-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/10042681/eaacb3a74c17/aging-15-204575-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/10042681/7df15528ee92/aging-15-204575-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09e6/10042681/c0a11704cf8f/aging-15-204575-g003.jpg

相似文献

1
Cytokine profiles of plasma extracellular vesicles as progression biomarkers in Parkinson's disease.血浆细胞外囊泡细胞因子谱作为帕金森病进展的生物标志物。
Aging (Albany NY). 2023 Mar 9;15(5):1603-1614. doi: 10.18632/aging.204575.
2
Cytokine Profile in Plasma Extracellular Vesicles of Parkinson's Disease and the Association with Cognitive Function.帕金森病患者血浆细胞外囊泡中的细胞因子谱及其与认知功能的关系。
Cells. 2021 Mar 9;10(3):604. doi: 10.3390/cells10030604.
3
Plasma extracellular vesicle synaptic proteins as biomarkers of clinical progression in patients with Parkinson's disease.血浆细胞外囊泡突触蛋白作为帕金森病患者临床进展的生物标志物。
Elife. 2024 Mar 14;12:RP87501. doi: 10.7554/eLife.87501.
4
Plasma extracellular vesicle tau, β-amyloid, and α-synuclein and the progression of Parkinson's disease: a follow-up study.血浆细胞外囊泡中的tau蛋白、β-淀粉样蛋白和α-突触核蛋白与帕金森病的进展:一项随访研究。
Ther Adv Neurol Disord. 2023 Feb 1;16:17562864221150329. doi: 10.1177/17562864221150329. eCollection 2023.
5
Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.血浆神经丝轻链作为早期帕金森病姿势不稳步态障碍运动亚型的诊断和预后生物标志物的效用。
Mol Neurodegener. 2020 Jun 5;15(1):33. doi: 10.1186/s13024-020-00385-5.
6
Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.帕金森病患者血浆细胞外囊泡α-突触核蛋白水平。
Biomolecules. 2021 May 17;11(5):744. doi: 10.3390/biom11050744.
7
Peripheral inflammatory cytokines and motor symptoms in persons with Parkinson's disease.帕金森病患者的外周炎性细胞因子与运动症状
Brain Behav Immun Health. 2022 Mar 7;21:100442. doi: 10.1016/j.bbih.2022.100442. eCollection 2022 May.
8
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.NLRP3 炎性小体的系统激活和血浆 α-突触核蛋白水平与帕金森病的运动严重程度和进展相关。
J Neuroinflammation. 2020 Jan 8;17(1):11. doi: 10.1186/s12974-019-1670-6.
9
Association of Parkinson's disease-related pain with plasma interleukin-1, interleukin-6, interleukin-10, and tumour necrosis factor-α.帕金森病相关性疼痛与血浆白细胞介素-1、白细胞介素-6、白细胞介素-10及肿瘤坏死因子-α的关联
Neurosci Lett. 2018 Sep 14;683:181-184. doi: 10.1016/j.neulet.2018.07.027. Epub 2018 Jul 29.
10
Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease.血浆细胞外囊泡tau 和 β-淀粉样蛋白作为帕金森病认知功能障碍的生物标志物。
FASEB J. 2021 Oct;35(10):e21895. doi: 10.1096/fj.202100787R.

引用本文的文献

1
Comparison of Methods for Isolation and Characterization of Total and Astrocyte-Enriched Extracellular Vesicles From Human Serum and Plasma.从人血清和血浆中分离及鉴定总细胞外囊泡和富含星形胶质细胞的细胞外囊泡的方法比较
J Extracell Biol. 2025 Feb 14;4(2):e70035. doi: 10.1002/jex2.70035. eCollection 2025 Feb.
2
Association Between Levodopa with Inotrope Prescription and Mechanical Ventilation Dependence in People with Parkinson's Disease upon Septic Shock.左旋多巴与血管活性药物联用处方与帕金森病患者感染性休克后机械通气依赖的关系
J Clin Med. 2025 Jan 24;14(3):748. doi: 10.3390/jcm14030748.
3
Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases.

本文引用的文献

1
Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson's Disease.细胞外囊泡作为帕金森病新型诊断和预后生物标志物
Aging Dis. 2021 Sep 1;12(6):1494-1515. doi: 10.14336/AD.2021.0527. eCollection 2021 Sep.
2
Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease.血浆细胞外囊泡tau 和 β-淀粉样蛋白作为帕金森病认知功能障碍的生物标志物。
FASEB J. 2021 Oct;35(10):e21895. doi: 10.1096/fj.202100787R.
3
Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
不同神经退行性疾病中细胞外囊泡分子货物的共同和独特变化。
Cell Mol Life Sci. 2024 Dec 3;81(1):479. doi: 10.1007/s00018-024-05522-7.
4
Emerging Role of Extracellular Vesicles as Biomarkers in Neurodegenerative Diseases and Their Clinical and Therapeutic Potential in Central Nervous System Pathologies.细胞外囊泡作为神经退行性疾病生物标志物的新作用及其在中枢神经系统疾病中的临床和治疗潜力。
Int J Mol Sci. 2024 Sep 19;25(18):10068. doi: 10.3390/ijms251810068.
5
Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson's disease and related disorders: A systematic review and diagnostic meta-analysis.用于帕金森病及相关疾病准确诊断的体液细胞外囊泡:一项系统评价与诊断性荟萃分析
J Extracell Biol. 2023 Nov 13;2(11):e121. doi: 10.1002/jex2.121. eCollection 2023 Nov.
6
Emergence of Extracellular Vesicles as "Liquid Biopsy" for Neurological Disorders: Boom or Bust.细胞外囊泡作为神经疾病“液体活检”的出现:是繁荣还是衰落。
Pharmacol Rev. 2024 Feb 13;76(2):199-227. doi: 10.1124/pharmrev.122.000788.
血浆外泌体中α-突触核蛋白的种类及寡聚化和磷酸化α-突触核蛋白作为帕金森病潜在外周生物标志物的研究。
Neuroscience. 2021 Aug 10;469:79-90. doi: 10.1016/j.neuroscience.2021.06.033. Epub 2021 Jun 27.
4
Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.帕金森病患者血浆细胞外囊泡α-突触核蛋白水平。
Biomolecules. 2021 May 17;11(5):744. doi: 10.3390/biom11050744.
5
α-Synuclein in Plasma-Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease.血浆衍生细胞外囊泡中的α-突触核蛋白是帕金森病的潜在生物标志物。
Mov Disord. 2021 Nov;36(11):2508-2518. doi: 10.1002/mds.28639. Epub 2021 May 18.
6
Cytokine Profile in Plasma Extracellular Vesicles of Parkinson's Disease and the Association with Cognitive Function.帕金森病患者血浆细胞外囊泡中的细胞因子谱及其与认知功能的关系。
Cells. 2021 Mar 9;10(3):604. doi: 10.3390/cells10030604.
7
Comparison of Three Motor Subtype Classifications in Parkinson's Disease Patients.帕金森病患者三种运动亚型分类的比较
Front Neurol. 2020 Dec 23;11:601225. doi: 10.3389/fneur.2020.601225. eCollection 2020.
8
Altered Insulin Receptor Substrate 1 Phosphorylation in Blood Neuron-Derived Extracellular Vesicles From Patients With Parkinson's Disease.帕金森病患者血液中神经元衍生细胞外囊泡中胰岛素受体底物1磷酸化的改变
Front Cell Dev Biol. 2020 Dec 3;8:564641. doi: 10.3389/fcell.2020.564641. eCollection 2020.
9
Neurofilament light chain level in plasma extracellular vesicles and Parkinson's disease.血浆细胞外囊泡中的神经丝轻链水平与帕金森病
Ther Adv Neurol Disord. 2020 Dec 7;13:1756286420975917. doi: 10.1177/1756286420975917. eCollection 2020.
10
Artificial neural network based prediction of postthrombolysis intracerebral hemorrhage and death.基于人工神经网络的溶栓后颅内出血和死亡预测。
Sci Rep. 2020 Nov 25;10(1):20501. doi: 10.1038/s41598-020-77546-5.